Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599664 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones
A Phase 1 study of Urinary Calculi and Urinary Stones, sponsored by Omeros Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
- 2
- Study locations
NCT00599664 is a Phase 1 study of Urinary Calculi and Urinary Stones that has completed, run by Omeros Corporation. The registered enrollment target is 11 participants, below the 109-participant average among 3 other Urinary Calculi trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00599664, a Phase 1 study of Urinary Calculi and Urinary Stones, has completed, sponsored by Omeros Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
- 2
- Study locations
Study Summary
Evaluate the safety and systemic absorption of OMS201 following exposure during ureteroscopy.
Conditions Studied
Interventions
- DRUG Vehicle
- DRUG OMS201
Study Locations (2)
California
- UC Irvine Medical Center - Orange
Texas
- University of Texas Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00599664
The ClinicalTrials.gov registry entry for NCT00599664 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 3 other Urinary Calculi trials with a reported enrollment target (90% lower). The listed sponsor is Omeros Corporation, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Urinary Calculi appearing as the primary indexed condition, and to 2 interventions - of which Vehicle is the first listed.
NCT00599664 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.
Frequently Asked Questions
What is clinical trial NCT00599664 about?
NCT00599664 is a clinical study titled "Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones". Evaluate the safety and systemic absorption of OMS201 following exposure during ureteroscopy.
What is the current status of trial NCT00599664?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2007-12. Estimated completion is 2008-09.
What conditions does trial NCT00599664 study?
This clinical trial studies the following conditions: Urinary Calculi, Urinary Stones, Urinary Tract Stones.
What interventions are being tested in trial NCT00599664?
The interventions under investigation include: Vehicle (DRUG), OMS201 (DRUG).
Who is sponsoring clinical trial NCT00599664?
This trial is sponsored by Omeros Corporation, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00599664 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Calculi
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.